News | News By Subject | News by Disease News By Date | Search News

SARS (Severe Acute Respiratory Syndrome) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
SARS Cloaking System Gets Shut Down; Findings Could Pave The Way To New Vaccines, Purdue University Reveals     6/4/2014
Utrecht University Study Sheds Light On Virus That Causes SARS     1/6/2009
Mechanism Of SARS Lung Damage Identified     2/5/2008
SARS: a Model Disease     11/21/2007
Human Antibodies that Block Human and Animal SARS Viruses Identified     7/3/2007
No Treatments Helped SARS Victims, Study Finds     9/13/2006
Researchers Find "Secret Weapon" Used by SARS Virus     8/8/2006
Scientists Develop SARS Vaccine with Common Poultry Virus     7/20/2006
Hong Kong Scientist Given Top Honors For SARS Discovery     7/17/2006
Researchers Identify Mechanism Of SARS Attack     5/16/2006
Scientists Unlock More Secrets Of HIV And SARS When They Replicate     5/16/2006
Enzyme Inhibitors Block Replication Of SARS Virus     3/28/2006
Canadian Scientists Find Way To Boost Vaccine Production 100-Fold     2/3/2006
Genetic Link To SARS Vulnerability     12/19/2005
Bats Harbor SARS-Like Virus, May Be Disease Source     9/30/2005

Press Releases
Brighton Biotech, Inc. Acquires Exclusive Global License For Development, Commercialization Of Vaccines For MERS, SARS     10/20/2015
Tamir Biotechnology, Inc. (Formerly Known as Alfacell Corporation) (ACEL) Reports Positive Effect Against SARS Virus     7/21/2010
Hemispherx Biopharma (HEB) Release: New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen(R), an Experimental Therapeutic     2/8/2010
Novavax, Inc. (NVAX) Announces Proprietary Method to Create SARS Vaccine and Renewal of National Institutes of Health (NIH) Funding for SARS Vaccine Development     5/22/2008
PRB Pharmaceuticals Release: Study Confirms How Fractions Of The Flu Medicine VIRA 38 Inhibit SARS Virus     8/4/2005
AVI BioPharma, Inc. (AVII) Reports Continued Success In Preclinical Antiviral Efforts; Positive Results From Five Collaborations Presented At The International Congress Of Virology     7/26/2005
American Oriental Bioengineering, Inc.'s (AOBO.OB) Marketing Initiatives Enhance Results Of Recently Acquired Heilongjiang Songhuajiang Pharmaceutical Limited; New Subsidiary Generates $2.5 Million In New Purchase Orders     6/27/2005
Meridian Bioscience, Inc. (VIVO) Targets Biodefense Market By Providing Contract Services For BEI Resources     2/9/2005
Novavax, Inc. (NVAX) Receives SARS Vaccine Funding From National Institutes of Health (NIH)     2/4/2005
IOMAI Corporation Receives $2.9 Million Grant From National Institutes of Health (NIH) To Support Influenza Vaccination Using IOMAI's Skin Patch Technology     2/1/2005
AVI BioPharma, Inc. (AVII) Updates Progress On Infectious Disease Program Using NEUGENE Antisense Drugs For RNA Viruses     1/25/2005
Sinovac Biotech Ltd. (SNVBF) Releases Further Results From SARS Vaccine Phase I Human Clinical Trial     12/13/2004
Sinovac Biotech Ltd. (SNVBF): Phase I Human Clinical Trial Shows Its SARS Vaccine To Be Safe And To Induce SARS-Neutralizing Antibodies     12/6/2004
Lipid Sciences, Inc.'s (LIPD) Viral Advisory Board Reviews Viral Immunotherapy Research Program     11/29/2004
Hemispherx Biopharma (HEB) Initiates Alferon LDO Clinical Program In Collaboration With Princess Margaret Hospital In Hong Kong     11/22/2004